StockNews.com started coverage on shares of Regulus Therapeutics (NASDAQ:RGLS – Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Regulus Therapeutics Trading Up 3.4 % NASDAQ RGLS opened at $1.53 on Tuesday. The firm’s fifty day simple moving average is $1.33 […]
UBS Group started coverage on shares of BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) in a research report issued on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $15.00 price target on the stock. UBS Group’s price objective would indicate a potential upside of 40.06% from the company’s current price. BTSG […]
Investment analysts at StockNews.com initiated coverage on shares of Rubicon Technology (NASDAQ:RBCN – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “sell” rating on the semiconductor company’s stock. Rubicon Technology Trading Up 5.7 % RBCN stock opened at $0.77 on Friday. Rubicon Technology has a 12 month low […]
StockNews.com assumed coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance InVivo Therapeutics has a 52 week low of $0.22 and a 52 week high of $2.40. […]
StockNews.com initiated coverage on shares of Value Line (NASDAQ:VALU – Free Report) in a report released on Friday morning. The firm issued a hold rating on the financial services provider’s stock. Value Line Stock Performance VALU stock opened at $42.99 on Friday. The company has a market capitalization of $405.40 million, a PE ratio of […]